Logo-jida

Chairperson:

Abbas Delvarani, DDS: Lecturer and Instructor Emeritus, Department of Endodontics, Dental Branch, Islamic Azad University, Tehran, Iran.

Editor-in-Chief:

Hadi Assadian, DDS, MSc: Assistant Professor, Department of Endodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

Associate Editor:

Ardavan Parhizkar, DDS, PhD: Assistant Professor and Senior Research Scientist, Research Institute for Dental Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Visiting Assistant Professor, Department of Endodontics, School of Dentistry, Tehran University of Medical Science, Tehran, Iran

 

Language Editors: 
•Hadi Assadian, DDS, MSc: Assistant Professor, Department of Endodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
•Mojdeh Kalantar-Motamedi, DDS; Dentist, Private Practice

 

Technical Editor:

Ava Akbari: Senior Dentistry Student, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Executive Manager:

Maryam Ebrahimizadeh, MSc

Instructions for Authors

Quick Submission Facts

  • Peer Review Model: Double-blind (authors and reviewers are anonymous).
  • Reference Style: Vancouver (numerical superscripts).
  • Submission Portal: JIDA Online Submission System.
  • Plagiarism Check: All manuscripts are screened for similarity before peer review.
  • Article Processing Charges (APC): Please refer to our APC Policy.

The Journal of Iranian Dental Association (JIDA) welcomes high-quality submissions that contribute meaningfully to dental science, clinical practice, and public oral health. To ensure swift processing and peer review, all submissions must strictly adhere to the guidelines outlined below.

1. Article Types, Limits, and Reporting Standards

JIDA enforces the use of the EQUATOR Network reporting guidelines. Authors must submit the corresponding completed checklist alongside their manuscript.

Article Type Word Limit (Main Text) Max References Required Reporting Guideline
Original Research (Clinical/Lab) ~4,000 words 50 CONSORT (Trials) / STROBE (Observational) / ARRIVE (Animal)
Systematic Reviews & Meta-Analyses ~6,000 words Unlimited PRISMA (Must include Flow Diagram & PROSPERO ID)
Scoping / Umbrella Reviews 4,000 – 7,000 words Unlimited PRISMA-ScR / JBI Manual / AMSTAR 2
Narrative Reviews 3,000 – 6,000 words 100 N/A (Expert synthesis required)
Case Reports / Series ~1,500 words 20 CARE (Must include Patient Consent)
Commentaries 1,000 – 1,500 words 15 N/A
Letters to the Editor Max 600 words 5 N/A

2. Authorship and Ethical Standards

2.1. Authorship Criteria (ICMJE & CRediT)

Authorship is based on the four ICMJE criteria. All authors must have substantially contributed to the work, drafted or revised it critically, approved the final version, and agreed to be accountable for all aspects of the study. Authors must declare their specific contributions using the CRediT (Contributor Roles Taxonomy) in the Title Page.

2.2. Generative AI Policy

Artificial Intelligence (AI) tools and Large Language Models (LLMs) do not qualify for authorship. If AI tools were used for language editing, data analysis, or drafting, their use must be explicitly disclosed in the Declarations section. AI must not be used to fabricate data, images, or citations.

2.3. Ethical Approvals and Informed Consent

All studies involving human subjects, medical records, or animal models must obtain prior approval from a recognized institutional ethics committee. The ethical approval code must be stated in the Methods section. For Case Reports and clinical images, written informed consent for publication must be obtained from the patient and submitted to the journal.

3. Manuscript Preparation

To ensure a rigorous double-blind peer review, authors must submit their manuscript in two separate Microsoft Word files (.doc or .docx). Text should be typed in Times New Roman, 12 pt, double-spaced, with continuous line numbers.

File 1: Title Page (With Identity)

  • Full article title and running title (max 50 characters).
  • Full names, institutional affiliations, and ORCID iDs for all authors.
  • Corresponding author’s full contact details.
  • Word count, table/figure count.
  • CRediT authorship statement.
  • Declarations (Funding, COI, Ethics, AI Use).
  • Acknowledgments.

File 2: Blinded Manuscript (No Identity)

  • Title and Structured Abstract (max 250–300 words).
  • Keywords (3-6 MeSH terms).
  • Main Text (Introduction, Methods, Results, Discussion, Conclusion).
  • References (Vancouver style).
  • Tables and Figures legends.
  • CRITICAL: Remove all author names, institutional affiliations, and identifying grant numbers from this file.

4. Manuscript Structure (IMRAD)

  • Introduction: Provide the background, state the gap in the literature, and clearly define the study objectives/hypothesis.
  • Materials and Methods: Detail the study design, sample selection, interventions, and statistical analyses with sufficient clarity to allow replication. Include the ethics approval statement (with the institution name anonymized in the blinded file).
  • Results: Present findings logically using text, tables, and high-resolution figures (min 300 dpi). Do not duplicate data in tables and text. Report exact p-values and confidence intervals.
  • Discussion: Interpret the findings against existing literature. Acknowledge the study's strengths and limitations.
  • Conclusion: Provide a concise summary of the main outcomes and their clinical/scientific implications without overgeneralizing.

5. References

References must be formatted in Vancouver style. Citations in the text should be indicated by numerical superscripts in order of appearance. Prioritize recent, peer-reviewed journal articles. Ensure DOIs or URLs are provided where available. Authors are responsible for the accuracy of their citations.

6. Mandatory Declarations

The following statements must be included at the end of the Title Page:

  • Conflicts of Interest: "The authors declare that they have no competing interests." (Or detail any financial/personal relationships).
  • Funding: Disclose any grants, equipment, or financial support received for the study.
  • Data Availability: State whether the raw data is available in a public repository (provide DOI/Link) or available upon reasonable request from the corresponding author.
  • AI Disclosure: "No generative AI tools were used in the creation of this manuscript." (Or detail the tool, version, and exact application).

Author Pre-Submission Checklist

Before submitting via the online portal, ensure that:

  • The manuscript fits the Aims and Scope of JIDA.
  • The Title Page and Blinded Manuscript are uploaded as separate files.
  • Word limits and reference formatting (Vancouver) are strictly adhered to.
  • All mandatory declarations (COI, Funding, Ethics, AI) are present.
  • The appropriate EQUATOR reporting checklist (e.g., PRISMA, CONSORT) is uploaded as a supplementary file.
  • Signed patient consent forms (for Case Reports) are ready to be uploaded.